Insider Transactions Reported by 17 Insiders of Kezar Life Sciences, Inc.

Symbol
KZR on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Kezar Life Sciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Morningside Venture Investments Ltd 10%+ Owner $1.75M 15 Aug 2023
Mark C. Schiller Chief Operating Officer $11.7K -$2.4K -17% 02 Jul 2025
Pichi Luo Chiang SVP, Corporate Controller $11.6K -$1.13K -8.87% 02 Jul 2025
Noreen Henig Chief Medical Officer 24 Jul 2023
Courtney Wallace Director 18 Jun 2025
Jason Dinges Director 28 Jun 2021
Nicholas Michael Mordwinkin Chief Business Officer 07 Jan 2024
John Franklin Fowler Director 18 Jun 2025
Micki Klearman Director 18 Jun 2025
FRANKLIN BERGER Director 18 Jun 2025
Jean-Pierre Sommadossi Director 28 Jun 2021
Elizabeth Garner Director 18 Jun 2025
Christopher J. Kirk CEO, Director 09 Jan 2025
Zung Phuong To Chief Development Officer 01 Jul 2025
GRAHAM K. COOPER Director 18 Jun 2025
Michael Kauffman Director 18 Jun 2025
Marc Belsky Chief Financial Officer 27 Mar 2025

Recent Insider Transactions by Companies or Individuals for Kezar Life Sciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.